167 related articles for article (PubMed ID: 14578196)
21. Epidermal growth factor inhibits glycylsarcosine transport and hPepT1 expression in a human intestinal cell line.
Nielsen CU; Amstrup J; Steffansen B; Frokjaer S; Brodin B
Am J Physiol Gastrointest Liver Physiol; 2001 Jul; 281(1):G191-9. PubMed ID: 11408272
[TBL] [Abstract][Full Text] [Related]
22. Leptin transcriptionally enhances peptide transporter (hPepT1) expression and activity via the cAMP-response element-binding protein and Cdx2 transcription factors.
Nduati V; Yan Y; Dalmasso G; Driss A; Sitaraman S; Merlin D
J Biol Chem; 2007 Jan; 282(2):1359-73. PubMed ID: 16963449
[TBL] [Abstract][Full Text] [Related]
23. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter.
Han HK; Oh DM; Amidon GL
Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889
[TBL] [Abstract][Full Text] [Related]
24. Drug inhibition of Gly-Sar uptake and hPepT1 localization using hPepT1-GFP fusion protein.
Sun D; Landowski CP; Chu X; Wallsten R; Komorowski TE; Fleisher D; Amidon GL
AAPS PharmSci; 2001; 3(1):E2. PubMed ID: 11741253
[TBL] [Abstract][Full Text] [Related]
25. Regulation of intestinal hPepT1 (SLC15A1) activity by phosphodiesterase inhibitors is via inhibition of NHE3 (SLC9A3).
Anderson CM; Thwaites DT
Biochim Biophys Acta; 2007 Jul; 1768(7):1822-9. PubMed ID: 17498647
[TBL] [Abstract][Full Text] [Related]
26. Substrate specificity of the di/tripeptide transporter in human intestinal epithelia (Caco-2): identification of substrates that undergo H(+)-coupled absorption.
Thwaites DT; Hirst BH; Simmons NL
Br J Pharmacol; 1994 Nov; 113(3):1050-6. PubMed ID: 7858848
[TBL] [Abstract][Full Text] [Related]
27. Effect of ionization on the variable uptake of valacyclovir via the human intestinal peptide transporter (hPepT1) in CHO cells.
Balimane P; Sinko P
Biopharm Drug Dispos; 2000 Jul; 21(5):165-74. PubMed ID: 11180195
[TBL] [Abstract][Full Text] [Related]
28. Dipeptidomimetic ketomethylene isosteres as pro-moieties for drug transport via the human intestinal di-/tripeptide transporter hPEPT1: design, synthesis, stability, and biological investigations.
Våbenø J; Nielsen CU; Ingebrigtsen T; Lejon T; Steffansen B; Luthman K
J Med Chem; 2004 Sep; 47(19):4755-65. PubMed ID: 15341490
[TBL] [Abstract][Full Text] [Related]
29. Interferon-gamma increases expression of the di/tri-peptide transporter, h-PEPT1, and dipeptide transport in cultured human intestinal monolayers.
Foster DR; Landowski CP; Zheng X; Amidon GL; Welage LS
Pharmacol Res; 2009 Mar; 59(3):215-20. PubMed ID: 19084598
[TBL] [Abstract][Full Text] [Related]
30. Molecular identification of a role for tyrosine 167 in the function of the human intestinal proton- coupled dipeptide transporter (hPepT1).
Yeung AK; Basu SK; Wu SK; Chu C; Okamoto CT; Hamm-Alvarez SF; von Grafenstein H; Shen WC; Kim KJ; Bolger MB; Haworth IS; Ann DK; Lee VH
Biochem Biophys Res Commun; 1998 Sep; 250(1):103-7. PubMed ID: 9735340
[TBL] [Abstract][Full Text] [Related]
31. In vitro evaluation of N-methyl amide tripeptidomimetics as substrates for the human intestinal di-/tri-peptide transporter hPEPT1.
Andersen R; Nielsen CU; Begtrup M; Jørgensen FS; Brodin B; Frokjaer S; Steffansen B
Eur J Pharm Sci; 2006 Jul; 28(4):325-35. PubMed ID: 16713701
[TBL] [Abstract][Full Text] [Related]
32. Design, synthesis, and evaluation of tripeptidic promoieties targeting the intestinal peptide transporter hPEPT1.
Thorn K; Andersen R; Christensen J; Jakobsen P; Nielsen CU; Steffansen B; Begtrup M
ChemMedChem; 2007 Apr; 2(4):479-87. PubMed ID: 17407174
[TBL] [Abstract][Full Text] [Related]
33. Ibuprofen is a non-competitive inhibitor of the peptide transporter hPEPT1 (SLC15A1): possible interactions between hPEPT1 substrates and ibuprofen.
Omkvist DH; Brodin B; Nielsen CU
Br J Pharmacol; 2010 Dec; 161(8):1793-805. PubMed ID: 20726987
[TBL] [Abstract][Full Text] [Related]
34. Hormonal regulation of dipeptide transporter (PepT1) in Caco-2 cells with normal and anoxia/reoxygenation management.
Sun BW; Zhao XC; Wang GJ; Li N; Li JS
World J Gastroenterol; 2003 Apr; 9(4):808-12. PubMed ID: 12679938
[TBL] [Abstract][Full Text] [Related]
35. Correlation between epithelial cell permeability of cephalexin and expression of intestinal oligopeptide transporter.
Chu XY; Sánchez-Castaño GP; Higaki K; Oh DM; Hsu CP; Amidon GL
J Pharmacol Exp Ther; 2001 Nov; 299(2):575-82. PubMed ID: 11602669
[TBL] [Abstract][Full Text] [Related]
36. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
[TBL] [Abstract][Full Text] [Related]
37. Cephalexin inhibits N-formylated peptide transport and intestinal hyperpermeability in Caco2 cells.
Foster DR; Zheng X
J Pharm Pharm Sci; 2007; 10(3):299-310. PubMed ID: 17727793
[TBL] [Abstract][Full Text] [Related]
38. A quantitative structure-activity relationship for translocation of tripeptides via the human proton-coupled peptide transporter, hPEPT1 (SLC15A1).
Omkvist DH; Larsen SB; Nielsen CU; Steffansen B; Olsen L; Jørgensen FS; Brodin B
AAPS J; 2010 Sep; 12(3):385-96. PubMed ID: 20449699
[TBL] [Abstract][Full Text] [Related]
39. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter.
Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL
Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043
[TBL] [Abstract][Full Text] [Related]
40. Lactobacillus casei alters hPEPT1-mediated glycylsarcosine uptake in Caco-2 cells.
Neudeck BL; Loeb JM; Faith NG
J Nutr; 2004 May; 134(5):1120-3. PubMed ID: 15113956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
